283 related articles for article (PubMed ID: 30050803)
1. Magnetic resonance imaging (MRI)-based radiomics for prostate cancer radiotherapy.
Yang F; Ford JC; Dogan N; Padgett KR; Breto AL; Abramowitz MC; Dal Pra A; Pollack A; Stoyanova R
Transl Androl Urol; 2018 Jun; 7(3):445-458. PubMed ID: 30050803
[TBL] [Abstract][Full Text] [Related]
2. Prostate cancer radiomics and the promise of radiogenomics.
Stoyanova R; Takhar M; Tschudi Y; Ford JC; Solórzano G; Erho N; Balagurunathan Y; Punnen S; Davicioni E; Gillies RJ; Pollack A
Transl Cancer Res; 2016 Aug; 5(4):432-447. PubMed ID: 29188191
[TBL] [Abstract][Full Text] [Related]
3. The role of radiomics in prostate cancer radiotherapy.
Delgadillo R; Ford JC; Abramowitz MC; Dal Pra A; Pollack A; Stoyanova R
Strahlenther Onkol; 2020 Oct; 196(10):900-912. PubMed ID: 32821953
[TBL] [Abstract][Full Text] [Related]
4. Habitat escalated adaptive therapy (HEAT): a phase 2 trial utilizing radiomic habitat-directed and genomic-adjusted radiation dose (GARD) optimization for high-grade soft tissue sarcoma.
Naghavi AO; Bryant JM; Kim Y; Weygand J; Redler G; Sim AJ; Miller J; Coucoules K; Michael LT; Gloria WE; Yang G; Rosenberg SA; Ahmed K; Bui MM; Henderson-Jackson EB; Lee A; Lee CD; Gonzalez RJ; Feygelman V; Eschrich SA; Scott JG; Torres-Roca J; Latifi K; Parikh N; Costello J
BMC Cancer; 2024 Apr; 24(1):437. PubMed ID: 38594603
[TBL] [Abstract][Full Text] [Related]
5. Prediction of Clinically Significant Cancer Using Radiomics Features of Pre-Biopsy of Multiparametric MRI in Men Suspected of Prostate Cancer.
Ogbonnaya CN; Zhang X; Alsaedi BSO; Pratt N; Zhang Y; Johnston L; Nabi G
Cancers (Basel); 2021 Dec; 13(24):. PubMed ID: 34944819
[TBL] [Abstract][Full Text] [Related]
6. Multiparametric MRI to improve detection of prostate cancer compared with transrectal ultrasound-guided prostate biopsy alone: the PROMIS study.
Brown LC; Ahmed HU; Faria R; El-Shater Bosaily A; Gabe R; Kaplan RS; Parmar M; Collaco-Moraes Y; Ward K; Hindley RG; Freeman A; Kirkham A; Oldroyd R; Parker C; Bott S; Burns-Cox N; Dudderidge T; Ghei M; Henderson A; Persad R; Rosario DJ; Shergill I; Winkler M; Soares M; Spackman E; Sculpher M; Emberton M
Health Technol Assess; 2018 Jul; 22(39):1-176. PubMed ID: 30040065
[TBL] [Abstract][Full Text] [Related]
7. Multiparametric MRI in detection and staging of prostate cancer.
Boesen L
Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066
[TBL] [Abstract][Full Text] [Related]
8. Changes in Magnetic Resonance Imaging Radiomic Features in Response to Androgen Deprivation Therapy in Patients with Intermediate- and High-risk Prostate Cancer.
Tharmalingam H; Tsang YM; Alonzi R; Beasley W; Taylor NJ; McWilliam A; Padhani A; Choudhury A; Hoskin PJ
Clin Oncol (R Coll Radiol); 2022 Jun; 34(6):e246-e253. PubMed ID: 35033410
[TBL] [Abstract][Full Text] [Related]
9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
10. Guidance of treatment decisions in risk-adapted primary radiotherapy for prostate cancer using multiparametric magnetic resonance imaging: a single center experience.
Panje C; Panje T; Putora PM; Kim SK; Haile S; Aebersold DM; Plasswilm L
Radiat Oncol; 2015 Feb; 10():47. PubMed ID: 25880635
[TBL] [Abstract][Full Text] [Related]
11. Magnetic resonance imaging radiomic features for recurrent prostate cancer following proton radiation therapy-A pilot study.
Bazargani S; Feibus AH; Elshafei A; Al-Toubat M; Gopireddy DR; Gautam S; Barwari S; Henderson R; Lall C; Balaji KC; Bandyk M
Urol Oncol; 2023 Mar; 41(3):145.e1-145.e5. PubMed ID: 36496342
[TBL] [Abstract][Full Text] [Related]
12. The role of multiparametric magnetic resonance in active surveillance of a low-risk prostate cancer cohort from clinical practice.
Chamorro Castillo L; García Morales L; Ruiz López D; Salguero Segura J; Valero Rosa J; Anglada Curado FJ; Mesa Quesada J; Blanca Pedregosa A; Carrasco Valiente J; Gómez Gómez E
Prostate; 2023 Jun; 83(8):765-772. PubMed ID: 36895160
[TBL] [Abstract][Full Text] [Related]
13. The Role of Multiparametric Magnetic Resonance in Volumetric Modulated Arc Radiation Therapy Planning for Prostate Cancer Recurrence After Radical Prostatectomy: A Pilot Study.
Sardaro A; Turi B; Bardoscia L; Ferrari C; Rubini G; Calabrese A; Ammirati F; Grillo A; Leo A; Lorusso F; Santorsola A; Stabile Ianora AA; Scardapane A
Front Oncol; 2020; 10():603994. PubMed ID: 33585223
[TBL] [Abstract][Full Text] [Related]
14. Comparison of machine learning algorithms to predict clinically significant prostate cancer of the peripheral zone with multiparametric MRI using clinical assessment categories and radiomic features.
Bernatz S; Ackermann J; Mandel P; Kaltenbach B; Zhdanovich Y; Harter PN; Döring C; Hammerstingl R; Bodelle B; Smith K; Bucher A; Albrecht M; Rosbach N; Basten L; Yel I; Wenzel M; Bankov K; Koch I; Chun FK; Köllermann J; Wild PJ; Vogl TJ
Eur Radiol; 2020 Dec; 30(12):6757-6769. PubMed ID: 32676784
[TBL] [Abstract][Full Text] [Related]
15. Image-guided Raman spectroscopy navigation system to improve transperineal prostate cancer detection. Part 2: in-vivo tumor-targeting using a classification model combining spectral and MRI-radiomics features.
Grajales Lopera DO; Picot F; Shams R; Dallaire F; Sheehy G; Alley S; Barkati M; Delouya G; Carrier JF; Birlea M; Trudel D; Leblond F; Ménard C; Kadoury S
J Biomed Opt; 2022 Sep; 27(9):. PubMed ID: 36085571
[TBL] [Abstract][Full Text] [Related]
16. Magnetic resonance imaging in prostate cancer detection and management: a systematic review.
Monni F; Fontanella P; Grasso A; Wiklund P; Ou YC; Randazzo M; Rocco B; Montanari E; Bianchi G
Minerva Urol Nefrol; 2017 Dec; 69(6):567-578. PubMed ID: 28488844
[TBL] [Abstract][Full Text] [Related]
17. Prostate cancer tumour control probability modelling for external beam radiotherapy based on multi-parametric MRI-GTV definition.
Sachpazidis I; Mavroidis P; Zamboglou C; Klein CM; Grosu AL; Baltas D
Radiat Oncol; 2020 Oct; 15(1):242. PubMed ID: 33081804
[TBL] [Abstract][Full Text] [Related]
18. Histology core-specific evaluation of the European Society of Urogenital Radiology (ESUR) standardised scoring system of multiparametric magnetic resonance imaging (mpMRI) of the prostate.
Kuru TH; Roethke MC; Rieker P; Roth W; Fenchel M; Hohenfellner M; Schlemmer HP; Hadaschik BA
BJU Int; 2013 Dec; 112(8):1080-7. PubMed ID: 23937255
[TBL] [Abstract][Full Text] [Related]
19. Serial T2-Weighted Magnetic Resonance Images Acquired on a 1.5 Tesla Magnetic Resonance Linear Accelerator Reveal Radiomic Feature Variation in Organs at Risk: An Exploratory Analysis of Novel Metrics of Tissue Response in Prostate Cancer.
Lorenz JW; Schott D; Rein L; Mostafaei F; Noid G; Lawton C; Bedi M; Li XA; Schultz CJ; Paulson E; Hall WA
Cureus; 2019 Apr; 11(4):e4510. PubMed ID: 31259119
[TBL] [Abstract][Full Text] [Related]
20. Multiparametric Magnetic Resonance Imaging for Active Surveillance of Prostate Cancer.
An JY; Sidana A; Choyke PL; Wood BJ; Pinto PA; Türkbey İB
Balkan Med J; 2017 Sep; 34(5):388-396. PubMed ID: 28990929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]